UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of November 2023
Commission file number: 001-41387
SaverOne 2014 Ltd.
(Translation of registrant’s name into English)
Em Hamoshavot Rd. 94
Petah Tikvah, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
This Form 6-K, including all exhibits
hereto, is hereby incorporated by reference into the registrant’s Registration Statements on Form S-8 (File No.
333-274455) and Form F-3 (File No. 333-274458, 333-263338 and 333-269260), to be a part thereof from the date on
which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
CONTENTS
On November
3, 2023, SaverOne 2014 Ltd. (the “Company”) announced that it will hold a Special General Meeting of Shareholders on Thursday,
November 30, 2023 at 3:00 p.m. (Israel time) at the Company’s offices in Petah Tikva, Israel. In connection with the meeting, the
Company furnishes the following documents:
| 1. |
A copy of the Notice and Proxy Statement with respect to the Company’s Special General Meeting of Shareholders describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting, attached hereto as Exhibit 99.1; |
| 2. |
A form of Proxy Card whereby holders of ordinary shares of the Company may vote at the meeting without attending in person, attached hereto as Exhibit 99.2; and |
| 3. |
A form of Voting Instruction Card whereby holders of American Depositary Shares of the Company may vote at the meeting without attending in person, attached hereto as Exhibit 99.3. |
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
SaverOne 2014 Ltd. |
| |
|
| Date: November 3, 2023 |
By: |
/s/ Ori Gilboa |
| |
|
Name: |
Ori Gilboa |
| |
|
Title: |
Chief Executive Officer |
2
Exhibit 99.1
NOTICE OF
SPECIAL GENERAL MEETING OF SHAREHOLDERS
TO BE HELD ON NOVEMBER 30, 2023
To the shareholders and ADS
holders of SaverOne 2014 Ltd. (the “Company”):
Notice is hereby given that
the Special General Meeting of Shareholders (the “Meeting”) will be held on Thursday, November 30, 2023, at 3:00 p.m. Israel
time at our offices, Em Hamoshavot Rd. 94, Petah Tikva, Israel.
The agenda of the Meeting
will be to increase the Company’s authorized share capital by 900,000,000, such that following the increase, the authorized share
capital shall equal NIS 1,000,000 divided into 1,000,000,000 ordinary shares, par value NIS 0.01 each, and to amend the Company’s
articles of association accordingly.
Only shareholders and holders
of American Depositary Shares at the close of business on November 10, 2023 (the “Record Date”) are entitled to notice of,
and to vote at, the Meeting and any adjournment or postponement thereof. You are cordially invited to attend the Meeting in person.
If you are unable to attend
the Meeting in person, you are requested to complete, date and sign the enclosed proxy and to return it promptly in the pre-addressed
envelope provided. Shareholders who attend the Meeting may revoke their proxies and vote their shares in person.
Beneficial owners who hold
ordinary shares through members of the Tel Aviv Stock Exchange, or the TASE, may either vote their shares in person at the Meeting by
presenting a certificate signed by the TASE Clearing House member through which the shares are held, which complies with the Israel Companies
Regulations (Proof of Ownership for Voting in General Meetings)-2000 as proof of ownership of the shares on the Record Date, or send such
certificate along with a duly executed proxy (in the form filed by us on MAGNA, the distribution site of the Israeli Securities Authority,
at www.magna.isa.gov.il), to us at Em Hamoshavot Rd. 94, Petah Tikva, Israel 49130, Israel Attention: Chief Financial Officer.
| |
By Order of the Board of Directors |
| |
|
| |
Jacob Tenenboim |
| |
Chairman of the Board |
| |
November 3, 2023 |
Em Hamoshavot Rd.
94, Petah Tikva,
Israel
PROXY STATEMENT
FOR SPECIAL GENERAL MEETING OF SHAREHOLDERS
TO BE HELD ON NOVEMBER 30, 2023
This Proxy Statement is furnished
to our holders of ordinary shares, par value NIS 0.01 per share, including holders of our ordinary shares that are represented by American
Depository Shares, or ADSs, in connection with the Special General Meeting of Shareholders (the “Meeting”), to be held on
Thursday, November 30, 2023, at 3:00 p.m. Israel time at our offices, Em Hamoshavot Rd. 94, Petah Tikva, Israel, or at any adjournments
thereof.
Throughout this Proxy Statement,
we use terms such as “SaverOne”, “we”, “us”, “our” and the “Company” to refer
to SaverOne 2014 Ltd. and terms such as “you” and “your” to refer to our shareholders and ADS holders.
Agenda Items
The agenda of the Meeting
will be to increase the Company’s authorized share capital by 900,000,000, such that following the increase, the authorized share
capital shall equal NIS 1,000,000 divided into 1,000,000,000 ordinary shares, par value NIS 0.01 each, and to amend the Company’s
articles of association accordingly.
We currently are unaware of
any other matters that may be raised at the Meeting. Should any other matters be properly raised at the Meeting, the persons designated
as proxies shall vote according to their own judgment on those matters.
Board Recommendation
Our Board of Directors unanimously
recommends that you vote “FOR” the proposal on the agenda.
Who Can Vote
Only shareholders and ADS
holders at the close of business on November 10, 2023, shall be entitled to receive notice of and to vote at the Meeting.
How You Can Vote
You can vote your ordinary
shares by attending the Meeting. If you do not plan to attend the Meeting, the method of voting will differ for shares held as a record
holder, shares held in “street name” (through a Tel Aviv Stock Exchange, or TASE, member) and shares underlying ADSs that
you hold. Holders of ADSs (whether registered in their name or in “street name”) will receive voting instruction cards in
order to instruct their banks, brokers or other nominees on how to vote.
Shareholders of Record
If you are a shareholder of
record, you can submit your vote by completing, signing and submitting an applicable proxy, which has been published at www.magna.isa.gov.il
and www.maya.tase.co.il and which will be accessible at the “Investor Relations” portion of our website, as described below
under “Shareholder Meetings”.
Shareholders Holding in
“Street Name,” Through the TASE
If you hold ordinary shares
in “street name,” that is, through a bank, broker or other nominee that is admitted as a member of the TASE, your shares will
only be voted if you provide instructions to the bank, broker or other nominee as to how to vote, or if you attend the Meeting in person.
If voting by mail, you must
sign and date a proxy and attach to it a certificate signed by the TASE Clearing House member through which the shares are held, which
complies with the Israel Companies Regulations (Proof of Ownership for Voting in General Meetings)-2000 as proof of ownership of the shares,
as applicable, on the Record Date, and return the proxy, along with the proof of ownership certificate, to us, as described in the instructions
available on MAGNA.
If you choose to attend the
Meeting (where ballots will be provided), you must bring the proof of ownership certificate from the TASE’s Clearing House member
through which the shares are held, indicating that you were the beneficial owner of the shares, as applicable, on the Record Date.
Holders of ADSs
Under the terms of the Deposit
Agreement between the Company, The Bank of New York Mellon, as depositary, or BNY Mellon, and the holders of our ADSs, BNY Mellon shall
endeavor (insofar as is practicable) to vote or cause to be voted the number of shares represented by ADSs in accordance with the instructions
provided by the holders of ADSs to BNY Mellon. For ADSs that are held in “street name”, through a bank, broker or other nominee,
the voting process will be based on the underlying beneficial holder of the ADSs directing the bank, broker or other nominee to arrange
for BNY Mellon to vote the ordinary shares represented by the ADSs in accordance with the beneficial holder’s voting instructions.
If no instructions are received by BNY Mellon from any holder of ADSs (whether held directly by a beneficial holder or in “street
name”) with respect to any of the shares represented by the ADSs on or before the date established by BNY Mellon for such purpose,
BNY Mellon shall not vote or attempt to vote the shares represented by such ADSs.
Multiple Record Holders
or Accounts
You may receive more than
one set of voting materials, including multiple copies of this document or voting instruction cards. For example, shareholders who hold
ADSs in more than one brokerage account will receive a separate voting instruction card for each brokerage account in which ADSs are held.
You should complete, sign, date and return each voting instruction card you receive.
Our Board of Directors urges
you to vote your shares so that they will be counted at the Meeting or at any postponements or adjournments of the Meeting.
Solicitation
Shareholders and ADS holders
may vote at the Meeting whether or not they attend. If a properly executed proxy is received by us at least 48 hours prior to the Meeting
(and received by BNY Mellon no later than the date indicated on the voting instruction card, in the case of ADS holders), all of the shares
represented by the proxy shall be voted as indicated on the form or, if no preference is noted, shall be voted in favor of the matter
described above, and in such manner as the holder of the proxy may determine with respect to any other business as may come before the
Meeting or any adjournment thereof. Shareholders and ADS holders may revoke their proxy at any time before the deadline for receipt of
powers of attorney by filing with us (in the case of holders of ordinary shares) or with BNY Mellon (in the case of holders of ADSs),
a written notice of revocation or duly executed proxy bearing a later date.
Proxies are being distributed to shareholders and ADS holders on or
about November 16, 2023. Certain officers, directors, employees, and agents of ours, none of whom will receive additional compensation
therefor, may solicit proxies by telephone, emails, or other personal contact. We will bear the cost for the solicitation of the proxies,
including postage, printing, and handling, and will reimburse the reasonable expenses of brokerage firms and others for forwarding material
to beneficial owners of shares and ADSs.
To the extent you would like
to submit a position statement with respect to the proposal described in this proxy statement pursuant to the Companies Law, 5759-1999
(the “Israeli Companies Law”), you may do so by delivery of appropriate notice to our offices (Attention: Chief Financial
Officer) located at Em Hamoshavot Rd. 94, Petah Tikva, 49130, Israel, not later than ten days before the Meeting. Response of the board
to the position statement may be submitted not later than five days before the Meeting.
Quorum
At the close of business on November 1, 2023, we had outstanding 30,204,991
ordinary shares. Each ordinary share (including ordinary shares represented by ADSs) outstanding as of the close of business on the Record
Date is entitled to one vote upon the matter to be voted on at the Meeting.
Under our articles of association, the Meeting will be properly convened
if at least two shareholders attend the meeting in person or sign and return proxies, provided that they hold shares representing at least
25% of our voting power. If such quorum is not present within half an hour from the time scheduled for the Meeting, the Meeting will be
adjourned to December 3, 2023 (to the time and place). No further notice will be given or publicized with respect to such adjourned meeting.
At the reconvened meeting, if there is no quorum within half an hour from the time scheduled for the meeting, any number of our shareholders
present in person or by proxy shall constitute a lawful quorum.
Vote Required for the Proposal
Proposal 1 to be presented
at the Meeting requires the affirmative vote of holders of at least a majority of the voting power represented and voting on such proposal
in person or by proxy on the matter presented for passage.
If you provide specific instructions
(mark boxes) with regard to the proposal, your shares will be voted as you instruct. If you sign and return your proxy card or voting
instruction form without giving specific instructions, your shares will be voted in accordance with the recommendations of our Board of
Directors. The proxy holders will vote in their discretion on any other matters that properly come before the meeting.
If you are a shareholder of
record and do not return your proxy card, your shares will not be voted. If you hold shares (or ADSs representing shares) beneficially
in street name, your shares will also not be voted at the meeting if you do not return your proxy card or voting instruction card to instruct
your broker or BNY Mellon how to vote. A broker (and BNY Mellon) may only vote in accordance with instructions from a beneficial owner
of shares or ADSs.
Availability of Proxy Materials
Copies of the applicable proxy
card and voting instruction card, the Notice of the Special General Meeting of Shareholders and this Proxy Statement are available at
the “Investor Relations” portion of our website, www.saver.one. The contents of that website are not a part of this Proxy
Statement.
Reporting Requirements
We are subject to the information
reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, applicable to foreign private issuers.
We fulfill these requirements by filing reports with the Securities and Exchange Commission, or Commission. Our filings with the Commission
may be inspected without charge at the Commission’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information
on the operation of the Public Reference Room can be obtained by calling the Commission at 1-800-SEC-0330. Our filings are also available
to the public on the Commission’s website at http://www.sec.gov.
As a foreign private issuer,
we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements. The circulation of this
notice and proxy statement should not be taken as an admission that we are subject to the proxy rules under the Exchange Act.
EXECUTIVE OFFICER COMPENSATION
For
information regarding the compensation incurred by the Company in relation to our five most highly compensated office holders (within
the meaning of the Israeli Companies Law) for the year ended December 31, 2022, see “Item 6B. Compensation — Compensation
of Directors and Senior Management” of the Company’s Annual Report on Form 20-F, which was filed on April 27, 2023.
PROPOSAL 1:
PROPOSAL TO INCREASE AUTHORIZED SHARE CAPITAL
Background
Our authorized share capital is NIS 1,000,000 divided into 100,000,000
ordinary shares, par value NIS 0.01 each. As of November 1, 2023, we had 30,204,991 ordinary shares issued and outstanding and we had
no preferred shares outstanding. In addition , as of November 1, 2023, 1,944,730 ordinary shares issuable upon exercise of options
outstanding under our SaverOne 2014 Ltd. 2015 Share Incentive Plan (the “2015 Plan”), 900,000 restricted ordinary shares units
outstanding under the 2015 Plan, 155,270 ordinary shares reserved for future issuance under our 2015 Plan, 787,550 ordinary
shares issuable upon the exercise of warrants granted to the underwriters in connection with our initial public offering in the United
States in June 2022 (the “IPO”) and 16,383,410 ordinary shares issuable upon the exercise of warrants sold in our IPO. Accordingly,
49,624,049 ordinary shares remain unissued and unreserved.
The proposal to increase the
authorized share capital of the Company is designed to enable us to have sufficient authorized share capital for the upcoming years and
in order that the increase in authorized share capital would allow us to meet our future business needs as they arise. These needs could
include, among other things, the sale of shares in public and private offerings to raise additional capital, the purchase of property
or assets, the acquisition of other companies, the use of shares for various equity compensation and other employee benefit plans and
arrangements, the declaration of share splits or dividends, and other bona fide corporate purposes.
The possible future issuance
of equity securities consisting of ordinary shares, ADSs or securities convertible into ordinary shares could affect our current shareholders
in a number of ways, including the following: (i) diluting the voting power of the current holders of ordinary shares or ADSs; (ii) diluting
the market price of the ordinary shares or ADSs, to the extent that the new ordinary shares or ADSs are issued and sold at prices below
current trading prices of the existing ordinary shares or ADSs, or if the issuance consists of equity securities convertible into ordinary
shares or ADSs, to the extent that the securities provide for the conversion into ordinary shares or ADSs at prices that could be below
current trading prices of the ordinary shares or ADSs; and (iii) diluting the book value per share of the outstanding ordinary shares
or ADSs.
Proposed Resolutions
It is proposed that at the
Meeting the following resolution be adopted:
“RESOLVED, that the
increase to our authorized share capital by 900,000,000, such that following the increase, the authorized share capital shall equal NIS
1,000,000 divided into 1,000,000,000 ordinary shares, par value NIS 0.01 each, and the corresponding amendment to our articles of association
be, and hereby is, approved in all respects.”
Required Vote
Under the Israeli Companies
Law and our articles of association, the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting,
in person or by proxy, entitled to vote and voting on the matter, is required for this proposal.
Board Recommendation
Our Board of Directors recommends
a vote FOR the increase in our authorized share capital and corresponding amendment to our articles of association as specified above.
OTHER BUSINESS
Other than as set forth above,
as of the mailing of this Proxy Statement, management knows of no business to be transacted at the Meeting, but, if any other matters
are properly presented at the Meeting, the persons named in the enclosed form of proxy will vote upon such matters in accordance with
their best judgment.
YOU SHOULD RELY ONLY ON THE
INFORMATION CONTAINED IN THIS PROXY STATEMENT OR THE INFORMATION FURNISHED TO YOU IN CONNECTION WITH THIS PROXY STATEMENT WHEN VOTING
ON THE MATTERS SUBMITTED TO SHAREHOLDER AND ADS HOLDERS VOTE HEREUNDER. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION
THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THIS DOCUMENT. THIS PROXY STATEMENT IS DATED NOVEMBER 3, 2023. YOU SHOULD NOT ASSUME THAT
THE INFORMATION CONTAINED IN THIS DOCUMENT IS ACCURATE AS OF ANY DATE OTHER THAN NOVEMBER 3, 2023, AND THE MAILING OF THIS DOCUMENT TO
SHAREHOLDERS AND ADS HOLDERS SHOULD NOT CREATE ANY IMPLICATION TO THE CONTRARY.
| |
By Order of the Board of Directors |
| |
|
| |
Jacob Tenenboim |
| |
Chairman of the Board |
| |
November 3, 2023 |
6
Exhibit 99.2
SAVERONE 2014 LTD.
PROXY
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD
OF DIRECTORS
The undersigned shareholder
of SaverOne 2014 Ltd. (the “Company”) hereby appoints Ori Gilboa, Chief Executive Officer, and Omri Hagai, Chief Financial
Officer, or any of them, agents and proxies of the undersigned, with full power of substitution to each of them, to represent and to vote
on behalf of the undersigned all the ordinary shares of the Company which the undersigned is entitled to vote at the Special General Meeting
of Shareholders (the “Meeting”) to be held at the offices of the Company at Em Hamoshavot Rd. 94, Petah Tikva, Israel, on
Thursday, November 30, 2023, at 3:00 p.m. Israel time and at any adjournments or postponements thereof, upon the following matters, which
are more fully described in the Notice of Special General Meeting of Shareholders and Proxy Statement relating to the Meeting.
The undersigned acknowledges
receipt of the Notice of Special General Meeting of Shareholders and Proxy Statement of the Company relating to the Meeting.
This Proxy, when properly
executed, will be voted in the manner directed herein by the undersigned. If no direction is made with respect to any matter, this Proxy
will be voted FOR such matter. Any and all proxies heretofore given by the undersigned are hereby revoked.
(Continued and to be signed on the reverse side)
SPECIAL GENERAL MEETING OF SHAREHOLDERS OF
SAVERONE 2014 LTD.
NOVEMBER 30, 2023
THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR”
EACH OF THE PROPOSALS FOR THE MEETING
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE
ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE ☒
| |
1. |
To increase the Company’s authorized share capital by 900,000,000, such that following the increase, the authorized share capital shall equal NIS 1,000,000 divided into 1,000,000,000 ordinary shares, par value NIS 0.01 each, and to amend the Company’s articles of association accordingly. |
| |
☐ |
FOR |
☐ |
AGAINST |
☐ |
ABSTAIN |
In their discretion, the proxies are authorized
to vote upon such other matters as may properly come before the Meeting or any adjournment or postponement thereof.
| |
|
|
|
_____________, 2023 |
| NAME |
|
SIGNATURE |
|
DATE |
| |
|
|
|
_____________, 2023 |
| NAME |
|
SIGNATURE |
|
DATE |
Please sign exactly as your name appears on this
Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, trustee or guardian, please give
full title as such. If the signed is a corporation, please sign full corporate name by duly authorized officer, giving full title as such.
If signer is a partnership, please sign in partnership name by authorized person.
Exhibit 99.3
SaverOne 2014 (NASDAQ:SVRE)
Historical Stock Chart
From Apr 2024 to May 2024
SaverOne 2014 (NASDAQ:SVRE)
Historical Stock Chart
From May 2023 to May 2024
